CD5 and mantle cell lymphoma: We analyzed the peripheral blood and BM samples of 131 patients with B-cell CLDs (including 91 CLL, 15 atypical CLL, 14 MCL, and 11 CD5-/CD10-lymphoma patients) from April 2018 to April 2019, using a panel of specific markers by flow cytometry.